y 27632 has been researched along with 2019 Novel Coronavirus Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almeida, CR; Alves, JV; Auxiliadora-Martins, M; Avila-Mesquita, CD; Becari, C; Campos, LCB; Costa, RM; Couto, AES; Lima, JF; Lobato, NS; Louzada-Júnior, P; Machado, MR; Tostes, RC | 1 |
| Liu, X; Mondal, AM | 1 |
1 review(s) available for y 27632 and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Conditional cell reprogramming for modeling host-virus interactions and human viral diseases.
Topics: Amides; Animals; Antiviral Agents; Cellular Reprogramming; Coculture Techniques; COVID-19; COVID-19 Drug Treatment; Drug Discovery; Epithelial Cells; Host Microbial Interactions; Humans; Immunity, Innate; Pyridines; SARS-CoV-2; Virus Internalization | 2020 |
1 other study(ies) available for y 27632 and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Inhibition of IL-6 signaling prevents serum-induced umbilical cord artery dysfunction from patients with severe COVID-19.
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Arteries; COVID-19; Cytokines; Female; Humans; Interleukin-6; Pregnancy; Reactive Oxygen Species; rho-Associated Kinases; Serotonin; Umbilical Cord | 2023 |